Tax Provision - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Tax Provision Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Tax Provision
-$480k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Tax Provision
-$3.1B
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Tax Provision
-$109m
CAGR 3-Years
51%
CAGR 5-Years
38%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Tax Provision
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Tax Provision
-$1.5B
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Tax Provision
-$1.6B
CAGR 3-Years
-22%
CAGR 5-Years
-54%
CAGR 10-Years
-7%

See Also

What is Xeris Biopharma Holdings Inc's Tax Provision?
Tax Provision
-480k USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Tax Provision amounts to -480k USD.

Back to Top